Strategic Investment Advisors Moderna, Inc. Transaction History

Strategic Investment Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	BUY	$69.51 - $104.43 $570,538 - $857,161	8,208 Added 128.67%	14,587 $1.45 Million
Q3 2023 Oct 24, 2023	BUY	$96.41 - $126.61 $204,967 - $269,172	2,126 Added 49.99%	6,379 $658,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $760,651 - $1.03 Million	-6,419 Reduced 60.15%	4,253 $516,000
Q1 2023 Apr 27, 2023	BUY	$135.66 - $197.02 $845,704 - $1.23 Million	6,234 Added 140.47%	10,672 $1.64 Million
Q4 2022 Jan 19, 2023	SELL	$118.38 - $210.04 $1,657 - $2,940	-14 Reduced 0.31%	4,438 $0
Q3 2022 Oct 27, 2022	SELL	$118.07 - $194.18 $4,132 - $6,796	-35 Reduced 0.78%	4,452 $527,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $22,488 - $33,905	192 Added 4.47%	4,487 $641,000
Q1 2022 Apr 28, 2022	BUY	$126.46 - $235.05 $543,145 - $1.01 Million	4,295 New	4,295 $740,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.